Abstract
It is estimated that about 2% to 5% of pancreatic malignant tumors are metastatic lesions. Lung, kidney and breast cancer as well as melanoma are the most common primary tumors affecting the pancreas. Histologic or cytologic confirmation is essential for differential diagnosis from the much more common primary adenocarcinoma of the pancreas. The aim of this study is to assess the diagnostic value and safety of endoscopic ultrasound guided-fine needle aspiration (EUS-FNA) of pancreatic tumors in patients with extra-pancreatic malignancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
